Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP CLI: Cilostazol Triple vs Dual Therapy in CLI
NCT02829151Phase 4Unknown
- Sponsor
- Yonsei University
- Start
- Feb 2017
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol in critical limb ischemia (CLI), sponsored by Yonsei University. Status: unknown.
02
Drugs
cilostazol
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT02829151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02829151.